OHE submission to the UK Parliamentary Inquiry on an Ageing Society

OHE’s written submission to parliament focused on raising population health in older age and increasing access to fertility treatments as two possible avenues to address the challenges of demographic change.

Publications

Taking STRIDES: The Value of Diagnostics Against AMR

10 June 2025

Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance…

A stethoscope laying on a map

Altering the Trajectory of HIV in Europe

22 May 2025

Despite substantial medical advancements that have transformed HIV into a…

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

1 May 2025

The National Institute for Health and Care Excellence (NICE) is the body…

Insights

The Trump Administration’s US Drug Pricing Proposal – What will happen next?

12 June 2025

This is the second in our series of Insights considering the implications of…

How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices

11 June 2025

As healthcare systems strive to allocate resources efficiently, the use of…

Around the world in HTAs: Argentina – Long Road to Institutionalizing HTA

9 June 2025

In this Insights series, Around the World in HTAs, we shed light on HTA around…

Stats & facts

 

Adult immunisation programmes can offset their cost multiple times

Likelihood of developing dementia, becoming informal carer, or both in a lifetime

Total preventable burden of cervical cancer in the UK


Areas of expertise

OHE's expertise covers a wide range of topics.

Health Technology Assessment (HTA)

Reflections from the Region: Healthcare transformation in the Middle East

It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is…

How Widely Are QALYs Used in OECD Countries? A Snapshot of International Practices

As healthcare systems strive to allocate resources efficiently, the use of economic evaluation metrics like…

Drug Development/R&D

The Trump Administration’s US Drug Pricing Proposal – What will happen next?

This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most…

Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines

Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS…

Digital Health

OHE’s submission for the DHSC’s next 10 years of planning

This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation…

A man standing on one side of a chasm and the globe is on the other side.

Green Healthcare: Are We Asking the Right Questions?

The climate-health crisis is a growing global concern, and identifying the right starting points is crucial.

Prevention

Valuing Health in an Era of Climate Crisis: Informing Policy through Economic Evidence

This panel brings together leading researchers to explore how health economics can inform policy design in the context of…

Reflections from the Region: Healthcare transformation in the Middle East

It’s not often that you witness a health system reinvent itself in real-time. And yet, this is precisely what is…

Events

OHE events sharing innovation and insights

Valuing Health in an Era of Climate Crisis: Informing Policy through Economic Evidence

8 July 2025, 10:00am

This panel brings together leading researchers to explore how health economics can inform policy design in the context of…

2024 Innovation Policy Prize Award Ceremony

28 January 2025, 6:00pm

During this evening, we will award the £40,000 fund to the winners, Andrew Briggs and Thomas Pogge, who will present their…

Insights and Reflections from 2024

8 January 2025, 3:00pm

Our panel of OHE experts covered the research trends that had the biggest impact in 2024, with oversights of: …

The Price of Success: Can innovative payment models support access to combination therapies in Europe?

5 December 2024, 3:00pm

This panel considered the arguments for and against a system of differential pricing for combination therapies in Europe.…